Human Reproduction, Vol. 17, No. 11, 2839-2841,
November 2002
© 2002 European Society of Human Reproduction and Embryology
Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure
1 Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 and 2 CREST, Japan Science and Technology, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and methodsResults and discussionAcknowledgementsReferences |
|---|
BACKGROUND: There is broad human exposure to bisphenol A (BPA), an estrogenic endocrine-disrupting chemical widely used for the production of plastic products. BPA is reported to affect preimplantation embryos or fetuses and alter their postnatal development at doses typically found in the environment. We measured contamination of BPA in various kinds of human biological fluids by a novel enzyme-linked immunosorbent assay. METHODS: Blood samples were obtained from healthy premenopausal women, women with early and full-term pregnancy, and umbilical cord at full-term delivery. Ovarian follicular fluids obtained during IVF procedures and amniotic fluids obtained at mid-term and full-term pregnancy were also subject to BPA measurements. RESULTS: BPA was present in serum and follicular fluid at
1–2 ng/ml, as well as in fetal serum and full-term amniotic fluid, confirming passage through the placenta. Surprisingly, an 5-fold higher concentration, 8.3 ± 8.7 ng/ml, was revealed in amniotic fluid at 15–18 weeks gestation, compared with other fluids. CONCLUSION: These results suggest accumulation of BPA in early fetuses and significant exposure during the prenatal period, which must be considered in evaluating the potential for human exposure to endocrine-disrupting chemicals.
Key words: amniotic fluid/bisphenol A/endocrine disruptor/fetus/pregnancy
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and methodsResults and discussionAcknowledgementsReferences |
|---|
Bisphenol A (BPA), an estrogenic endocrine-disrupting chemical, is produced at a value of
1.7 billion kg per annum worldwide and used in the production of polycarbonate plastics and epoxy resins, which are used in dentistry, food packaging, and as lacquers to coat food cans, bottletops and water pipes. Thus, there is broad human exposure to BPA, which can act at the very low doses detected in the environment (Sheehan, 2000
). BPA administered to pregnant mice is transferred to fetuses and alters postnatal development and sexual maturity at doses typically found in the environment (2.4 µg/kg) (Howdeshell et al., 1999). We also reported that BPA not only affects early embryonic development at a low, environmentally relevant level (0.23 ng/ml) (Takai et al., 2000), but also exerts late effects on postnatal development in mice (Takai et al., 2001). Moreover, many other studies have detected low dose effects of BPA in mice (Nagel et al., 1997; vom Saal et al., 1998; Gupta, 2000; Markey et al., 2001), rats (Steinmetz et al., 1997; Ramos et al., 2001), fish (Lindholst et al., 2000; Metcalfe et al., 2001), snails (Oehlmann et al., 2000), and frogs (Kloas et al., 1999).
Recently we measured serum BPA concentrations by a novel enzyme-linked immunosorbent assay (Kodaira et al., 2000) and detected BPA in all human sera (Takeuchi and Tsutsumi, 2002). Thus, it is of great importance to determine the precise levels of human and fetal contamination with BPA.
|
Materials and methods |
|---|
|
TopAbstractIntroductionMaterials and methodsResults and discussionAcknowledgementsReferences |
|---|
We used a novel enzyme-linked immunosorbent assay (ELISA) for BPA (Kodaira et al., 2000
; Takeuchi and Tsutsumi, 2002), which was recently developed by Otsuka Assay Laboratories and Yanaihara Institute Inc., to determine contamination in human biological fluids, obtained with informed consent. Briefly, the assay range was 0.5–5000 ng/ml of BPA. The ranges of the intra- and inter-assay coefficients of variation were 3.6–10.8 and 6.3–8.4% respectively. No cross-reactivity was observed toward other chemicals except for bis-(hydroxyphenyl)butane, bis-(hydroxyphenyl)ethane and bis-(hydroxymethylphenyl)propane (Kodaira et al., 2000). Blood samples were obtained from 30 healthy premenopausal women (non-pregnant) and 37 women with early pregnancy. Thirty-seven maternal (late pregnancy) and 32 umbilical cord blood samples were also obtained at full-term delivery. Thirty-six ovarian follicular fluids were aspirated during IVF procedures. Thirty-two and 38 amniotic fluids were obtained by amniocentesis at 15–18 weeks gestation (early pregnancy) and by amniotomy at full-term Caesarean section (late pregnancy) respectively. No chromosomal abnormalities or major anomalies were found in these fetuses.
Statistical analyses among the groups were performed by Kruskal–Wallis test. P < 0.05 was chosen to indicate a statistically significant difference.
|
Results and discussion |
|---|
|
TopAbstractIntroductionMaterials and methodsResults and discussionAcknowledgementsReferences |
|---|
As shown in Figure 1
, BPA was present in serum and follicular fluid at 2.0 ± 0.8 (mean ± SD; non-pregnant), 1.5 ± 1.2 (early pregnancy), 1.4 ± 0.9 (late pregnancy) and 2.4 ± 0.8 ng/ml (follicular fluid), as well as in fetal serum (2.2 ± 1.8 ng/ml) and amniotic fluid, confirming passage through the placenta. There was no significant correlation between the maternal and fetal serum concentrations (data not shown), suggesting that BPA may be partly metabolized in the fetus. There was approximately a 5-fold difference in BPA concentrations between amniotic fluid obtained at 15–18 weeks gestation (8.3 ± 8.9 ng/ml) and other fluids (P < 0.0001). However, amniotic fluid levels decreased significantly at term (1.1 ± 1.0 ng/ml) and no longer differed from the levels of other fluids.
|
) represent mean values. Number of samples appears in parentheses. *P < 0.0001 compared with other biological fluids.To verify the results of our ELISA for BPA in the amniotic fluid samples, we compared BPA values obtained by our ELISA with those by the conventional reverse-phase high-performance liquid chromatography (HPLC) analysis. The results showed a significant linear correlation between the two procedures (R = 0.93, P < 0.0001, data not shown). The origin of amniotic fluid in the first half of pregnancy presumably is the transudation of fluid from maternal plasma across the membranes that cover the placenta and the cord, because in composition the fluid is almost identical to a transudate of plasma. In the second half of pregnancy, there is a progressive admixture of fetal urine. From this point of view, in the first half of pregnancy BPA is transferred from maternal plasma to amniotic fluid and accumulated in the uterine cavity because of low metabolic clearance of BPA. Accordingly, a fetus is exposed to a large amount of BPA. Although its metabolism in the human body is largely unknown, BPA may be glucuronidated by a liver enzyme, uridine diphosphonate glucuronosyl transferase (UGT) (Yokota et al., 1999
). Significantly higher levels of BPA in the mid-term amniotic fluid indicate accumulation and subsequent significant exposure, and may be explained by immature liver function including UGT activity. In the second half of pregnancy, a fetus can swallow a large amount of amniotic fluid and conjugate BPA concomitantly with the maturation of liver function. Because BPA presumably returns via placenta from fetus to mother or is diluted by fetal urine, BPA levels in amniotic fluid may decrease at term. Indeed, the HPLC analysis revealed that the percentage of glucuronidated BPA in the mid-term amniotic fluid (34 ± 9%) was less than half of that in other human biological fluids (>90%) (our unpublished observation) and in rat urine (57–84%) obtained after oral administration of BPA (Pottenger et al., 2000). Since it was reported that BPA glucuronidate did not show appreciable efficacy in test systems for activation of in-vitro estrogen receptors 
and ß (Snyder et al., 2000), human mid-term amniotic fluid contains not only significantly elevated total (intact plus metabolized) BPA, but also significantly elevated biologically active molecules of BPA. There is much to be elucidated about the involvement of early BPA exposure in the recent phenomena in humans, such as increased genital abnormalities in boys (Paulozzi et al., 1997), earlier sexual maturation in girls (Herman-Giddens et al., 1997), decreased sperm count in men (Carlsen et al., 1992), and increased breast cancer in women (Brewster and Helzlsouer, 2001).
|
Acknowledgements |
|---|
|
TopAbstractIntroductionMaterials and methodsResults and discussionAcknowledgementsReferences |
|---|
We are grateful to Dr Yasuaki Usuki at Otsuka Assay Laboratories for help in measuring BPA concentration. We thank Drs Yutaka Osuga and Akihiko Suenaga at Tokyo University Hospital, Haruo Masuda at Tokyo Metropolitan Bokuto General Hospital, Seiichiro Obata at Hamada Hospital, Hisaya Ikeshita at Ikeshita Ladies and Children’s Hospital for help in obtaining samples. We also thank the reviewers of the Journal for helpful comments which were partly incorporated into our manuscript. This study was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, from the Ministry of Health, Labour and Welfare, and from the National Institute for Environmental Studies, Japan.
|
Notes |
|---|
3 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: osamut-tky{at}umin.ac.jp
|
References |
|---|
|
TopAbstractIntroductionMaterials and methodsResults and discussionAcknowledgementsReferences |
|---|
Brewster, A. and Helzlsouer, K. (2001) Breast cancer epidemiology, prevention, and early detection. Curr. Opin. Oncol., 13, 420–425.[ISI][Medline]
Carlsen, E., Giwercman, A., Keiding, N. and Skakkebaek, N.E. (1992) Evidence for decreasing quality of semen during past 50 years. Br. Med. J., 305, 609–613.[ISI][Medline]
Gupta, C. (2000) Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc. Soc. Exp. Biol. Med., 224, 61–68.
Herman-Giddens, M.E., Slora, E.J., Wasserman, R.C., Bourdony, C.J., Bhapkar, M.V., Koch, G.G. and Hasemeier, C.M. (1997) Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics, 99, 505–512.
Howdeshell, K.L., Hotchkiss, A.K., Thayer, K.A., Vandenbergh, J.G. and vom Saal, F.S. (1999) Exposure to bisphenol A advances puberty. Nature, 401, 763–764.[Medline]
Kloas, W., Lutz, I. and Einspanier, R. (1999) Amphibians as a model to study endocrine disruptors: II. Estrogenic activity of environmental chemicals in vitro and in vivo. Sci. Total Environ., 225, 59–68.[Medline]
Kodaira, T., Kato, I., Li, J., Mochizuki, T., Hoshino, M., Usuki, Y., Oguri, H. and Yanaihara, N. (2000) A novel ELISA for the measurement of immunoreactive bisphenol A. Biomed. Res., 21, 117–121.
Lindholst, C., Pedersen, K.L. and Pedersen, S.N. (2000) Estrogenic response of bisphenol A in rainbow trout (Oncorhynchus mykiss). Aquatic Toxicol., 48, 87–94.[ISI][Medline]
Markey, C.M., Luque, E.H., Munoz De Toro, M., Sonnenschein, C. and Soto, A.M. (2001) In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol. Reprod., 65, 1215–1223.
Metcalfe, C.D., Metcalfe, T.L., Kiparissis, Y., Koenig, B.G., Khan, C., Hughes, R.J., Croley, T.R., March, R.E. and Potter, T. (2001) Estrogenic potency of chemicals detected in sewage treatment plant effluents as determined by in vivo assays with Japanese medaka (Oryzias latipes). Environ. Toxicol. Chem., 20, 297–308.[ISI][Medline]
Nagel, S.C., vom Saal, F.S., Thayer, K.A., Dhar, M.G., Boechler, M. and Welshons, W.V. (1997) Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect., 105, 70–76.[ISI][Medline]
Oehlmann, J., Schulte-Oehlmann, U., Tillmann, M. and Markert, B. (2000) Effects of endocrine disruptors on prosobranch snails (Mollusca: Gastropoda) in the laboratory. Part I: Bisphenol A and octylphenol as xeno-estrogens. Ecotoxicology, 9, 383–397.[ISI][Medline]
Paulozzi, L.J., Erickson, J.D. and Jackson, R.J. (1997) Hypospadias trends in two US surveillance systems. Pediatrics, 100, 831–834.
Pottenger, L.H., Domoradzki, J.Y., Markham, D.A., Hansen, S.C., Cagen, S.Z. and Waechter, J.M., Jr (2000) The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci., 54, 3–18.
Ramos, J.G., Varayoud, J., Sonnenschein, C., Soto, A.M., Munoz De Toro, M. and Luque, E.H. (2001) Prenatal exposure to low doses of bisphenol A alters the periductal stroma and glandular cell function in the rat ventral prostate. Biol. Reprod., 65, 1271–1277.
Sheehan, D.M. (2000) Activity of environmentally relevant low doses of endocrine disruptors and the bisphenol A controversy: initial results confirmed. Proc. Soc. Exp. Biol. Med., 224, 57–60.
Snyder, R.W., Maness, S.C., Gaido, K.W., Welsch, F., Sumner, S.C. and Fennell, T.R. (2000) Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol., 168, 225–234.[ISI][Medline]
Steinmetz, R., Brown, N.G., Allen, D.L., Bigsby, R.M. and Ben-Jonathan, N. (1997) The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology, 138, 1780–1786.
Takai, Y., Tsutsumi, O., Ikezuki, Y., Hiroi, H., Osuga, Y., Momoeda, M., Yano, T. and Taketani, Y. (2000) Estrogen receptor-mediated effects of a xenoestrogen, bisphenol A, on preimplantation mouse embryos. Biochem. Biophys. Res. Commun., 270, 918–921.[ISI][Medline]
Takai, Y., Tsutsumi, O., Ikezuki, Y., Kamei, Y., Osuga, Y., Yano, T. and Taketan, Y. (2001) Preimplantation exposure to bisphenol A advances postnatal development. Reprod. Toxicol., 15, 71–74.[ISI][Medline]
Takeuchi, T. and Tsutsumi, O. (2002) Serum bisphenol A concentrations showed gender differences, possibly linked to androgen levels. Biochem. Biophys. Res. Commun., 291, 76–78.[ISI][Medline]
vom Saal, F.S., Cooke, P.S., Buchanan, D.L., Palanza, P., Thayer, K.A., Nagel, S.C., Parmigiani, S. and Welshons, W.V. (1998) A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol. Ind. Health, 14, 239–260.[ISI][Medline]
Yokota, H., Iwano, H., Endo, M., Kobayashi, T., Inoue, H., Ikushiro, S. and Yuasa, A. (1999) Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver. Biochem. J., 340, 405–409.
Submitted on March 28, 2002; accepted on July 23, 2002.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. A. Fowler, N. J. Dora, H. McFerran, M. R. Amezaga, D. W. Miller, R. G. Lea, P. Cash, A. S. McNeilly, N. P. Evans, C. Cotinot, et al. In utero exposure to low doses of environmental pollutants disrupts fetal ovarian development in sheep Mol. Hum. Reprod., May 1, 2008; 14(5): 269 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Brown Jr Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia Schizophr Bull, January 31, 2008; (2008) sbm147v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Moral, R. Wang, I. H Russo, C. A Lamartiniere, J. Pereira, and J. Russo Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature J. Endocrinol., January 1, 2008; 196(1): 101 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Monje, J. Varayoud, E. H Luque, and J. G Ramos Neonatal exposure to bisphenol A modifies the abundance of estrogen receptor {alpha} transcripts with alternative 5'-untranslated regions in the female rat preoptic area J. Endocrinol., July 1, 2007; 194(1): 201 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. N. Vandenberg, M. V. Maffini, P. R. Wadia, C. Sonnenschein, B. S. Rubin, and A. M. Soto Exposure to Environmentally Relevant Doses of the Xenoestrogen Bisphenol-A Alters Development of the Fetal Mouse Mammary Gland Endocrinology, January 1, 2007; 148(1): 116 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Smith and H. S. Taylor Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development FASEB J, January 1, 2007; 21(1): 239 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Savabieasfahani, K. Kannan, O. Astapova, N. P. Evans, and V. Padmanabhan Developmental Programming: Differential Effects of Prenatal Exposure to Bisphenol-A or Methoxychlor on Reproductive Function Endocrinology, December 1, 2006; 147(12): 5956 - 5966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Rubin, J. R. Lenkowski, C. M. Schaeberle, L. N. Vandenberg, P. M. Ronsheim, and A. M. Soto Evidence of Altered Brain Sexual Differentiation in Mice Exposed Perinatally to Low, Environmentally Relevant Levels of Bisphenol A Endocrinology, August 1, 2006; 147(8): 3681 - 3691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Tanaka, S Nakaya, M Katayama, H Leffers, S Nozawa, R Nakazawa, T Iwamoto, and S Kobayashi Effect of prenatal exposure to bisphenol A on the serum testosterone concentration of rats at birth Human and Experimental Toxicology, July 1, 2006; 25(7): 369 - 373. [Abstract] [PDF]
|
|
|
|
|
|
W. V. Welshons, S. C. Nagel, and F. S. vom Saal Large Effects from Small Exposures. III. Endocrine Mechanisms Mediating Effects of Bisphenol A at Levels of Human Exposure Endocrinology, June 1, 2006; 147(6): s56 - s69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hiroi, K. Okada, S. Imaoka, M. Osada, and Y. Funae Bisphenol A Binds to Protein Disulfide Isomerase and Inhibits Its Enzymatic and Hormone-Binding Activities Endocrinology, June 1, 2006; 147(6): 2773 - 2780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zsarnovszky, H. H. Le, H.-S. Wang, and S. M. Belcher Ontogeny of Rapid Estrogen-Mediated Extracellular Signal-Regulated Kinase Signaling in the Rat Cerebellar Cortex: Potent Nongenomic Agonist and Endocrine Disrupting Activity of the Xenoestrogen Bisphenol A Endocrinology, December 1, 2005; 146(12): 5388 - 5396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Volkel, N. Bittner, and W. Dekant QUANTITATION OF BISPHENOL A AND BISPHENOL A GLUCURONIDE IN BIOLOGICAL SAMPLES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY Drug Metab. Dispos., November 1, 2005; 33(11): 1748 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ooe, T. Taira, S. M. M. Iguchi-Ariga, and H. Ariga Induction of Reactive Oxygen Species by Bisphenol A and Abrogation of Bisphenol A-Induced Cell Injury by DJ-1 Toxicol. Sci., November 1, 2005; 88(1): 114 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Munoz-de-Toro, C. M. Markey, P. R. Wadia, E. H. Luque, B. S. Rubin, C. Sonnenschein, and A. M. Soto Perinatal Exposure to Bisphenol-A Alters Peripubertal Mammary Gland Development in Mice Endocrinology, September 1, 2005; 146(9): 4138 - 4147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sugiura-Ogasawara, Y. Ozaki, S.-i. Sonta, T. Makino, and K. Suzumori Exposure to bisphenol A is associated with recurrent miscarriage Hum. Reprod., August 1, 2005; 20(8): 2325 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Teeguarden, J. M. Waechter Jr., H. J. Clewell III, T. R. Covington, and H. A. Barton Evaluation of Oral and Intravenous Route Pharmacokinetics, Plasma Protein Binding, and Uterine Tissue Dose Metrics of Bisphenol A: A Physiologically Based Pharmacokinetic Approach Toxicol. Sci., June 1, 2005; 85(2): 823 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Markey, P. R. Wadia, B. S. Rubin, C. Sonnenschein, and A. M. Soto Long-Term Effects of Fetal Exposure to Low Doses of the Xenoestrogen Bisphenol-A in the Female Mouse Genital Tract Biol Reprod, June 1, 2005; 72(6): 1344 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Timms, K. L. Howdeshell, L. Barton, S. Bradley, C. A. Richter, and F. S. vom Saal Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra PNAS, May 10, 2005; 102(19): 7014 - 7019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Zoeller, R. Bansal, and C. Parris Bisphenol-A, an Environmental Contaminant that Acts as a Thyroid Hormone Receptor Antagonist in Vitro, Increases Serum Thyroxine, and Alters RC3/Neurogranin Expression in the Developing Rat Brain Endocrinology, February 1, 2005; 146(2): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. B. Wetherill, N. L. Fisher, A. Staubach, M. Danielsen, R. W. de Vere White, and K. E. Knudsen Xenoestrogen Action in Prostate Cancer: Pleiotropic Effects Dependent on Androgen Receptor Status Cancer Res., January 1, 2005; 65(1): 54 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Heringa, B. van der Burg, J. C. H. van Eijkeren, and J. L. M. Hermens Xenoestrogenicity in In Vitro Assays Is Not Caused by Displacement of Endogenous Estradiol from Serum Proteins Toxicol. Sci., November 1, 2004; 82(1): 154 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.'i. Yoshihara, T. Mizutare, M. Makishima, N. Suzuki, N. Fujimoto, K. Igarashi, and S. Ohta Potent Estrogenic Metabolites of Bisphenol A and Bisphenol B Formed by Rat Liver S9 Fraction: Their Structures and Estrogenic Potency Toxicol. Sci., March 1, 2004; 78(1): 50 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Ramos, J. Varayoud, L. Kass, H. Rodriguez, L. Costabel, M. Munoz-de-Toro, and E. H. Luque Bisphenol A Induces Both Transient and Permanent Histofunctional Alterations of the Hypothalamic-Pituitary-Gonadal Axis in Prenatally Exposed Male Rats Endocrinology, July 1, 2003; 144(7): 3206 - 3215. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||